| HOME >> MEDICINE >> TECHNOLOGY |
References
1. Goss PE, Ingle JN, Pater JL, et al. Late extended adjuvant treatment
with letrozole improves outcome in women with early-stage breast cancer
completing 5 years of tamoxifen. J Clin Oncol. 2008
2. Ingle JN, Tu D. Pater JL , et al. Intent-to-treat analysis of the
placebo-controlled trial of letrozole for extended adjuvant therapy in
early breast cancer: NCIC CTG MA.17. Annals of Oncology. 2008
Contact Information
Megan Humphrey
Novartis Pharmaceuticals Corporation
1-862-778-6724
Dana Kahn Cooper
Cooper Communications
1-732-239-6664
dana@dcoopercommunications.com
| SOURCE Novartis Pharmaceuticals Corporation Copyright©2008 PR Newswire. All rights reserved |